Optimizing Uptake of Long-Acting Injectable Pre-exposure Prophylaxis for HIV Prevention for Men Who Have Sex with Men

Overview of attention for article published in AIDS and Behavior, January 2023

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#37 of 3,699)
High Attention Score compared to outputs of the same age (97th percentile)
High Attention Score compared to outputs of the same age and source (95th percentile)

Mentioned by

news: 12 news outlets
blogs: 2 blogs

twitter: 9 X users

Citations

dimensions_citation: 11 Dimensions

Readers on

mendeley: 8 Mendeley

Summary News Blogs X Dimensions citations

So far, Altmetric has seen 2 posts from 2 blogs.

Long-Acting Injectable Preferred for HIV Preexposure Prophylaxis

Physician's Weekly, 11 Feb 2023

FRIDAY, Feb. 10, 2023 (HealthDay News) — Long-acting injectable preexposure prophylaxis (PrEP) is the preferred HIV prevention…

Side-effects and costs are important issues for users of HIV pre-exposure prophylaxis, survey finds

news-medical.net, 01 Feb 2023

A new survey finds that men who would be potential users of HIV pre-exposure prophylaxis (PrEP) medication prefer long-acting…

This page shows the most recent blog posts that mention this research output.

Click here to find out how to access more activity.